Fischer has slight uptick in revenues

Article

Fischer Imaging appeared to make some progress in its 1997 fourth quarter toward turning the company around, posting an increase in quarterly revenues for the first time in fiscal 1997. But the news wasn't all good: The company reported a net loss for

Fischer Imaging appeared to make some progress in its 1997 fourth quarter toward turning the company around, posting an increase in quarterly revenues for the first time in fiscal 1997. But the news wasn't all good: The company reported a net loss for the year of $13.3 million.

For the fourth quarter (end-December), Fischer posted revenues of $14.8 million, up 1.2% over the $14.6 million reported in the fourth quarter of 1996, when Fischer first felt the impact of a sharp drop in shipments to OEMs. The company reported a net loss of $4.1 million, compared with a net loss of $2.6 million last year.

Despite the slight improvement in quarterly revenues, Fischer's annual figures remained well off last year's performance. For 1997, Fischer had revenues of $56.9 million, a dip of 26.6% compared with 1996 revenues of $77.5 million. The company's net loss swelled from $361,000 in 1996 to $13.3 million in 1997. The 1997 loss included a $2.9 million restructuring charge for consolidation of the firm's manufacturing facilities.

The company's financial performance has been plagued by the loss of OEM business from GE Medical Systems. In recent months, however, the Denver-based firm has moved to shore up its OEM base, landing agreements with Johnson & Johnson and Imagyn Medical Technologies (SCAN 10/29/97). Fischer also has a relationship with Sterling Diagnostic Imaging to manufacture that company's line of DirectRay digital detector systems.

Newsletter

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.